LEADER 00000cam  2200589 i 4500 
001    ocn864418087 
003    OCoLC 
005    20160513115020.0 
008    130905s2013    enka     b    001 0 eng   
010      2013431798 
015    GBB305234|2bnb 
016 7  101636297|2DNLM 
016 7  016256179|2Uk 
019    825557405|a847200169|a855019312 
020    9780199609147|q(pbk.) 
020    0199609144|q(pbk.) 
035    (OCoLC)864418087|z(OCoLC)825557405|z(OCoLC)847200169
       |z(OCoLC)855019312 
040    DLC|beng|erda|cDLC|dNLM|dOCLCO|dOCLCF|dCDX|dOCLCQ|dUKMGB
       |dYDXCP|dN5L|dGBVCP|dAU@|dSTJ 
042    pcc 
049    STJP 
050 00 RM301.28|b.P47 2013 
060 00 2014 H-620 
060 10 QV 39 
082 00 615.1|223 
096    QV 39|bP536 2013 
245 00 Pharmaceutical medicine /|cAdrian Kilcoyne, Medical 
       Director, Sanofi Pasteur MSD Ltd., Maidenhead, UK, Daniel 
       O'Connor, Medical Assessor, Medicines and Healthcare 
       Products Regulatory Agency (MHRA), London, UK, Phil Ambery,
       Director of Clinical Research, GlaxoSmithKline R & D, 
       London, UK. 
250    First edition. 
264  1 Oxford :|bOxford University Press,|c2013. 
300    xix, 452 pages :|billustrations ;|c18 cm. 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
490 1  Oxford specialist handbooks 
490 1  Oxford medical publications 
504    Includes bibliographical references and index. 
650  0 Clinical pharmacology. 
650  0 Drug development. 
650  7 Clinical pharmacology.|2fast|0(OCoLC)fst00864398 
650  7 Drug development.|2fast|0(OCoLC)fst00898670 
650  7 |0(DE-601)105449024|0(DE-588)4164215-6|aKlinische 
       Pharmazie.|2gnd 
650 12 Pharmaceutical Preparations. 
650 22 Pharmacy. 
650 22 Drug Therapy. 
655  2 Handbooks. 
700 1  Kilcoyne, Adrian,|eeditor. 
700 1  O'Connor, Daniel J.|c(Medical assessor),|eeditor. 
700 1  Ambery, Phil,|eeditor. 
830  0 Oxford medical publications. 
830  0 Oxford specialist handbooks. 
994    C0|bSTJ